Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is... see more

Recent & Breaking News (CSE:RVV)

Revive Therapeutics Provides Update on its Cannabis-based Pharmaceuticals Initiatives

GlobeNewswire September 5, 2018

Revive Therapeutics Provides Corporate Update

GlobeNewswire August 28, 2018

AXIM® Biotechnologies Enters Canadian Market Through New Exclusive Distribution and License Agreement With Revive Therapeutics

GlobeNewswire August 27, 2018

Revive Therapeutics Applies To FDA For Orphan Drug Designation of Cannabidiol For Treatment Of Liver Transplantation

GlobeNewswire August 22, 2018

Data Shows Medical Cannabis Will Dominate the Market by 2025

PR Newswire August 7, 2018

Cannabis Market Growth Accelerates as Cultivation Techniques Evolve

PR Newswire July 27, 2018

WeedMD Announces Results of Annual Meeting of Shareholders and Provides Corporate Update

GlobeNewswire July 16, 2018

Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Treatment of Autoimmune Hepatitis

GlobeNewswire June 27, 2018

Cannabis' Economic Impact to Expand With Emerging Markets

PR Newswire June 14, 2018

International Cannabis Legalization to Spur Global Medical and Recreational Sales

PR Newswire June 13, 2018

Revive Therapeutics and WeedMD Sign Medical Cannabis R&D Supply and Collaboration Agreements

GlobeNewswire June 13, 2018

WeedMD and Revive Therapeutics Sign Medical Cannabis R&D Supply and Collaboration Agreements

GlobeNewswire June 13, 2018

Revive Therapeutics Announces Results for the Three and Nine Months Ended March 31, 2018

GlobeNewswire May 30, 2018

Revive Therapeutics Announces Acceptance of Abstract for Cannabinoid Delivery Technology at 29th International Conference on Polyphenols and the 9th Tannin Conference

GlobeNewswire May 10, 2018

Revive Therapeutics Announces Exclusive License Agreement with Wisconsin Alumni Research Foundation for Cannabinoid Delivery Technology

GlobeNewswire April 30, 2018

Revive Therapeutics Retained Mi3 Communications for Investor Relations Services

GlobeNewswire March 28, 2018

Revive Therapeutics and Ehave Enter Into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program

GlobeNewswire March 1, 2018

Revive Therapeutics Announces Results for the Three and Six Months Ended December 31, 2017

GlobeNewswire February 27, 2018

Revive Therapeutics Submits Cannabinoid Delivery Technology Findings Abstract for 29th International Conference on Polyphenols and the 9th Tannin Conference

GlobeNewswire January 31, 2018

Revive Therapeutics Advances Research Program of Cannabinoid-Based Therapies Targeting Liver Diseases

GlobeNewswire January 30, 2018